European Surveillance of Clostridium difficile infections. Surveillance protocol version 2.1
ECDC publishes a protocol developed for the surveillance Clostridium difficile infections (CDI) to address the lack of standardised surveillance of CDI in EU Member States.
Country-to-country transfer of patients and the risk of multi-resistant bacterial infectionArchived
This review outlines how increasing modalities of travel, such as aeromedical evacuation of civilians and of military personnel, medical tourism and any shared healthcare across countries, are risks for the transmission of multidrug-resistant organisms via the patient, from country to country.
Healthcare-associated infections: Clostridium difficile infections - Annual Epidemiological Report for 2016
In 2016, 20 EU/EEA countries reported CDI data to ECDC for 593 surveillance periods from 556 hospitals.
European surveillance of Clostridium difficile infections - surveillance protocol version 2.3
This updated protocol prescribes the methodology, and provides the data collection tools required to achieve the objectives of European surveillance of CDIs.
European Surveillance of Clostridium difficile infections. Surveillance protocol version 2.2
This protocol prescribes the methodology, and provides the data collection tools required to achieve the objectives of European surveillance of Clostridium difficile infections (CDIs).
A review on the eco-epidemiology and clinical management of human granulocytic anaplasmosis and its agent in Europe
Matei, I.A., Estrada-Peña, A., Cutler, S.J., Vayssier-Taussat, M., Varela-Castro, L., Potkonjak, A., Zeller, H., Mihalca, A.D.
Application of a new methodology and R package reveals a high burden of healthcare-associated infections (HAI) in Germany compared to the average in the European Union/European Economic Area, 2011 to 2012
Zacher, B., Haller, S., Willrich, N., Walter, J., Abu Sin, M., Cassini, A., Plachouras, D., Suetens, C., Behnke, M., Gastmeier, P., Wieler, L.H., Eckmanns, T.
Antimicrobial use in European long-term care facilities: results from the third point prevalence survey of healthcare-associated infections and antimicrobial use, 2016 to 2017
Ricchizzi, E., Latour, K., Kärki, T., Buttazzi, R., Jans, B., Moro, M.L., Nakitanda, O.A., Plachouras, D., Monnet, D.L., Suetens, C., Kinross, P., The Halt Study Group
Clostridium difficile infection in Europe: A hospital-based survey
Bauer, M.P., Notermans, D.W., van Benthem, B.H., Brazier, J.S., Wilcox, M.H., Rupnik, M., Monnet, D.L., Van Dissel, J.T., Kuijper, E.J.